ad image

Company Info

PCI Pharma Services

PCI Pharma Services

CDMO / Supply Chain Logistics / Other

Overview

The global healthcare industry trusts PCI for the drug development solutions that increase their products’ speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches each year and over five decades in the healthcare services business. Leading technology and continued investment enable us to address global development needs throughout the product life cycle — from phase I clinical trials through commercialization and ongoing supply. Our clients view us as an extension of their business and a collaborative partner, with the shared goal of improving patients’ lives. For more information, please visit www.pci.com
PCI Pharma Services
Contributions
20 Contributions1 / 1
PCI Pharma Services
Pancreatic

PCI Pharma Services and ChiRhoClin Partner to Prevent Shortage of Critical Orphan Pancreatic Drug

PCI Pharma Services

PR-11-24-NI-114Nov 19, 2024
One of Our First Looks at the Burgeoning Australia Biotech Ecosystem
Clinical Trials

One of Our First Looks at the Burgeoning Australia Biotech Ecosystem

PCI Pharma Services

PAO-10-24-RTM-04Nov 04, 2024
PCI Pharma Services
Clinical Trials

PCI Pharma Services Wins Supply Chain Excellence Award for Digital Platform to Manage Clinical Trials and Commercial Lifespans

PCI Pharma Services

PR-10-24-NI-68Oct 30, 2024
PCI Pharma Services
CDMO

PCI Invests Over $365 Million in Facilities for Supply of Advanced Drug Delivery and Drug-Device Combination Products

PCI Pharma Services

PR-09-24-NI-15Sep 24, 2024
PCI Pharma Services
Sterile Fill-Finish

PCI Pharma Services Begins Installation of Sterile Fill-Finish and Lyophilization Line as Part of $100 Million New Facility Expansion

PCI Pharma Services

PR-M05-24-01May 02, 2024
PCI Pharma Services
ESG

Leading CDMO PCI Pharma Services Releases Inaugural Comprehensive ESG Report

PCI Pharma Services

PR-M03-24-04Mar 27, 2024
Controlled Substances in Clinical Trials: Considerations, Challenges, and Growing Demand
Controlled Substances in Clinical Trials

Controlled Substances in Clinical Trials: Considerations, Challenges, and Growing Demand

Rich Nelson; John Hufnagel; Rachel Castro

PCI Pharma Services

PAO-01-23-CL-03Jan 30, 2023
Accelerating Drug Development Using Robotic Sterile Fill-Finish Platforms
Robotic Sterile Fill-Finish

Accelerating Drug Development Using Robotic Sterile Fill-Finish Platforms

Jeff Clement; Mark Shepanski

PCI Pharma Services

PAO-10-022-CL-09Nov 11, 2022
PCI Pharma Services
Capacity Expansion

PCI Pharma Services Announces Major Manufacturing Expansion with $100 Million Investment in New England, Providing Global Capacity to Clients

PCI Pharma Services

PR-M05-22-05May 11, 2022
Discussing the Advancements in Oncology
Data Connectivity

Discussing the Advancements in Oncology

Tim Roberts

PCI Pharma Services

PATV-12-21-01Jan 19, 2022
An Evolving Biologics Landscape and Driving Innovation and Opportunity
Biologics

An Evolving Biologics Landscape and Driving Innovation and Opportunity

Tim Roberts

PCI Pharma Services

PAO-11-21-CL-16Nov 30, 2021
Delivering the Full Value Chain for Oncology Clinical Trials
Oncology Clinical Trials

Delivering the Full Value Chain for Oncology Clinical Trials

Tim Roberts

PCI Pharma Services

PAO-07-21-CL-09Aug 06, 2021
Seamlessly Sharing Supply Chain Information to Deliver Measurable Efficiencies for Clients
Digital Transformation

Seamlessly Sharing Supply Chain Information to Deliver Measurable Efficiencies for Clients

Morgan Brandt

PCI Pharma Services

PAP-Q4-20-CL-020Dec 09, 2020
PCI Pharma Services
M&A

Kohlberg and Mubadala Sign a Definitive Agreement to Acquire Majority Stake in PCI Pharma Services

PCI Pharma Services

PR-M08-20-NI-39Aug 25, 2020
The Power of Digital Transformation
 Digitization

The Power of Digital Transformation

Wayne Hull

PCI Pharma Services

PAP-Q2-20-CL-029Jul 01, 2020
Advanced, Flexible Packaging Solutions to Meet Parenteral Product Demand
Packaging

Advanced, Flexible Packaging Solutions to Meet Parenteral Product Demand

Dave Christmas; Alex Weaver

PCI Pharma Services

PAP-Q4-19-CL-026Dec 06, 2019
PCI Pharma Services
Capacity Expansion

PCI Unveils Expanded Clinical Center in Midwest

PCI Pharma Services

PR-M12-19-NI-006Dec 05, 2019
PCI Pharma Services
Serialization

PCI Pharma Services Announces Release of Joint White Paper with Domino on Ink Leachability in Pharmaceutical Serialization

PCI Pharma Services

PR-M09-17-NI-008Sep 20, 2017
PCI Pharma Services
Partnership

PCI Announces Further Investment in Specialized Labeling Capabilities

PCI Pharma Services

PR-M08-17-NI-011Sep 11, 2017
PCI Pharma Services
Capacity

PCI Pharma Services Announces Expansion of Cold Chain Capacity at Philadelphia Site

PCI Pharma Services

PR-M08-17-NI-010-5200Sep 06, 2017
1 / 1